(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FLUTRUXEV

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

FLUTRUXEV

ST13

US500000098892501

Class

5

Filing

98892501

Registration

8123342

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

02/04/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

12/09/2024

Registration date

02/03/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/03/2026

Last transaction

02/04/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Rixensart, BE

Examiner

WOOD,CAROLINE

Law office

M10

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

GlaxoSmithKline Biologicals SA

Representatives

Elizabeth K. Rucki GSK

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalhematologicalbacterialrespiratoryneurologicalgastrointestinaldermatologicalpsychiatricimmune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissuepaininflammationobesityinfectious diseases

Publications

History of USPTO decisions and trademark events.

21 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/03/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/03/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/16/2025

PUBO

PUBLISHED FOR OPPOSITION

12/16/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/10/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/16/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/17/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/17/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/17/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/14/2025

GNRT

NON-FINAL ACTION E-MAILED

10/14/2025

CNRT

NON-FINAL ACTION WRITTEN

10/14/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/15/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/15/2025

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/15/2025

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/30/2025

GNSL

LETTER OF SUSPENSION E-MAILED

05/30/2025

CNSL

SUSPENSION LETTER WRITTEN

05/30/2025

DOCK

ASSIGNED TO EXAMINER

05/28/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/09/2024

NWAP

NEW APPLICATION ENTERED

12/09/2024

Continuous trademark protection

Get notified about every new filing that threatens FLUTRUXEV or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.